These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3183451)

  • 1. Action of S 5682 on the complement system. In vitro and in vivo study.
    Di Perri T; Auteri A
    Int Angiol; 1988; 7(2 Suppl):11-5. PubMed ID: 3183451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drugs and the complement system. A condensation product of metacresolsulfonic acid and formaldehyde prevents instantly the complement activation in vitro.
    Gancevici GG; Popescu C
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):157-62. PubMed ID: 2634368
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement in vitro inhibition by a low-sulfate chondroitin sulfate (matrix).
    Biffoni M; Paroli E
    Drugs Exp Clin Res; 1991; 17(1):35-9. PubMed ID: 1833171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of a new non-steroid antiinflammatory drug, nimesulide, on activation of the complement system: an in vitro study.
    Auteri A; Saletti M; Blardi P; Di Perri T
    Int J Tissue React; 1988; 10(4):217-21. PubMed ID: 3250936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticomplement activity of a polyanion: pentosan sulfuric polyester. III. Mechanism of functional inactivation of the different properdin and complement system fractions].
    Berthoux FC; Freyria AM; Traeger J
    Pathol Biol (Paris); 1977 Mar; 25(3):179-84. PubMed ID: 323787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
    Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
    Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study.
    Lonchampt M; Guardiola B; Sicot N; Bertrand M; Perdrix L; Duhault J
    Arzneimittelforschung; 1989 Aug; 39(8):882-5. PubMed ID: 2818676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J; Schreyen H; Dorchy H
    Diabete Metab; 1992; 18(4):272-6. PubMed ID: 1459314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate inhibitors of porcine complement.
    Thorgersen EB; Ghebremariam YT; Thurman JM; Fung M; Nielsen EW; Holers VM; Kotwal GJ; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1827-34. PubMed ID: 17109963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of organic solvents on immunity indicators in serum.
    Stefanovic J; Starsia Z; Murgasová I; Absolonová O
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.